Streptococcus constellatus Infection Management
Introduction to Streptococcus constellatus
- S. constellatus belongs to the Streptococcus anginosus group, which can cause abscesses and serious infections, according to the European Heart Journal 2
- The American Academy of Otolaryngology-Head and Neck Surgery recommends against using Bactrim (trimethoprim-sulfamethoxazole) as first-line therapy for Streptococcus constellatus infections due to inadequate coverage and potential resistance 1
Antibiotic Selection for S. constellatus Infections
- Macrolide antibiotics and trimethoprim-sulfamethoxazole are not recommended for streptococcal infections due to high resistance rates, as stated by the American Academy of Otolaryngology-Head and Neck Surgery 1
- Trimethoprim-sulfamethoxazole shows resistance rates of up to 50% against Streptococcus pneumoniae, raising concerns for other streptococcal species, according to the American Academy of Otolaryngology-Head and Neck Surgery 1
- For patients with penicillin allergy, the American Academy of Otolaryngology-Head and Neck Surgery recommends respiratory fluoroquinolones (levofloxacin or moxifloxacin) as alternative therapy 1
Clinical Considerations for S. constellatus Infections
- S. constellatus often causes abscess formation in various body sites, as reported in the European Heart Journal 2
- Incision and drainage is the primary treatment for abscesses, with antibiotics as adjunctive therapy, according to Clinical Infectious Diseases 3, 4, 5
- Duration of therapy should typically be 7-14 days for skin and soft tissue infections, but may need to be longer for deep-seated infections, as stated in Clinical Infectious Diseases 3, 4
Special Considerations for S. constellatus Infections
- When S. constellatus is part of a mixed infection with MRSA, clindamycin alone or linezolid alone would provide adequate coverage for both organisms, according to Clinical Infectious Diseases 3, 4, 6
- For mixed infections with gram-negative organisms, broader coverage may be needed initially, as reported in Clinical Infectious Diseases 5